Pharmacological characterization of the rat A(2a) adenosine receptor functionally coupled to the yeast pheromone response pathway

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 829-837

  Price, Laura A ^a   Strnad, Joann ^a   Pausch, Mark H ^a   Hadcock, John R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; CYCLOHEXYLADENOSINE; HISTIDINE; PHENYLISOPROPYLADENOSINE; PHEROMONE;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REPORTER GENE; YEAST;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CELLS, CULTURED; GTP-BINDING PROTEINS; HUMANS; KIDNEY; KINETICS; PHENETHYLAMINES; PHEROMONES; RATS; RECEPTORS, PURINERGIC P1; RECEPTORS, SOMATOSTATIN; SACCHAROMYCES CEREVISIAE; TRITIUM;

EID: 0029862555     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Olah, M. E. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:581-606 (1995).
2. Libert, F., S. N. Schiffmann, A. Lefort, M. Parmentier, C. Gerard, J. E. Dumont, and J.-J. Vanderhaegen. The orphan receptor RDC7 encodes an A1 adenosine receptor. EMBO J. 10:1677-1682 (1990).
3. 2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173:1169-1178 (1990).
4. 2b receptor from human brain. Biochem. Biophys. Res. Commun. 187:86-93 (1992).
5. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89:7432-7436 (1992).
6. Londos, C., D. M. F. Cooper, and J. Wolff. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 77:2551-2554 (1980).
7. Fredholm, B. B., M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. A. Jacobson, P. Leff, and M. Williams. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:143-156 (1994).
8. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 251:47-55 (1989)
9. Niiya, K., R. A. Olsson, R. D. Thompson, S. K. Silva, and M. Ueeda. 2-(Ń-Alkkylidenehydrazino)adenosines: potent and selective coronary vasodilators. J. Med. Chem. 35:4557-4561 (1992).
10. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. Model systems for the study of seven-transmembrane segment receptors. Annu. Rev. Biochem. 60:653-388 (1991).
11. Sprague, G. F., and J. W. Thorner. Pheromone response and signal transduction during the mating process of Saccharomyces cerevisiae, in Gene Expression (J. R. Pringle, E. W. Jones, and J. R. Broach, eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 657-744 (1992). .
12. Price, L. A., E. M. Kajkowski, J. R. Hadcock, B. A. Ozenberger, and M. H. Pausch. Yeast cell growth in response to agonist-dependent activation of a mammalian somatostatin receptor. Mol. Cell. Biol. 15:6188-6195 (1995).
13. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Handbook. Cold Spring Harbor Press, Cold Spring Harbor, NY (1989).
14. 2-dopamine receptors in rat striatum. Mol. Brain Res. 14:186-195 (1992).
15. Ammerer, G. Expression of genes in yeast using the ADC1 promoter. Methods Enzymol. 101:192-212 (1983).
16. Rose, M., F. Winston, and P. Hieter. Methods in Yeast Genetics. Cold Spring Harbor Press, Cold Spring Harbor, NY (1990).
17. Burkolder, A. C. Genetic analysis of the receptor for the yeast pheromone alpha-factor. Ph.D. dissertation, University of Washington, Seattle (1986).
18. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:298-306 (1994).
19. Strnad, J., C. M. Eppler, M. Corbett, and J. R. Hadcock. The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation. Biochem. Biophys. Res. Commun. 191:968-976 (1993).
20. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
21. Blumer, K. J., J. E. Reneke, and J. Thorner. The STE2 gene product is the ligand-binding component of the α-factor receptor of Saccharomyces cerevisiae. J. Biol. Chem. 263:10836-10842 (1988).
22. 125I]iodophenyl)ethylamino]adenosine. Mol. Pharmacol. 47:307-313 (1995).
23. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29:331-346 (1986).
24. Kalckar, H. M. Differential spectrophotometry of purine compounds by means of specific enzymes. J. Biol. Chem. 167:461-475 (1947).
25. 2a-adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and activation of adenylate cyclase. Mol. Pharmacol. 41:352-359 (1991).
26. Weiner, J. L., C. Guttierez-Steil, and K. J. Blumer. Disruption of receptor-G protein coupling in yeast promotes the function of an SST2-dependent adaptation pathway. J. Biol. Chem. 268:8070-8077 (1995).
27. Tota, M. R., and M. I. Schimerlik. Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide binding protein in a reconstituted system. Mol. Pharmacol. 37:996-1004 (1990).
28. Hirsch, J. P., and F. R. Cross. The pheromone receptors inhibit the pheromone response pathway in Saccharomyces cerevisiae by a process that is independent of their associated Ga protein. Genetics 135:943-953 (1993).
29. s α subunit. Science (Washington D. C.) 250:121-123 (1990).
30. 2-adrenergic receptor expressed in Schizosaccharomyces pombe retains its pharmacological properties. FEBS Lett. 377:140-144 (1995).
31. Huang, H. J., C. F. Liao, B. C. Yang, and T. T. Kuo. Functional expression of rat M5 muscarinic acetylcholine receptor in yeast. Biochem. Biophys. Res. Commun. 182:1180-1186 (1992).
32. Payette, P., F. Gossard, M. Whiteway, and M. Dennis. Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett. 266:21-25 (1990).
33. 2s-dopamine receptor in yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe: a comparative study. FEBS Lett. 344:41-46 (1994).
34. Fredholm, B. B., M. P. Abbracchio, G. Burnstock, J. W. Daly, T. K. Harden, K. A. Jacobson, P. Leff, and M. Williams. VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:143-156.
35. Strosberg, A. D. Structure, function, and regulation of adrenergic receptors. Protein Sci. 2:1198-1209 (1993).
36. Raymond, J. R. Multiple mechanisms of receptor-G protein signaling specificity. Am. J. Physiol. 269:F141-F158 (1995).
37. 0 in reconstituted phospholipid vesicles. J. Biol. Chem. 264: 3909-3915 (1989).
38. Watkins, P. A., D. Burns, Y. Kanaho, T. Liu, E. Hewlett, and J. Moss. ADP-ribosylation of transducin by pertussis toxin, J. Biol. Chem. 260: 13478-13482 (1985).
39. α16 couple to a wide variety of receptors to phospholipase C. J. Biol. Chem. 270:15175-15180 (1995).
40. 2-adrenergic receptor to hematopoietic-specific G proteins. J. Biol. Chem. 270:16008-16010 (1995).